5.650GBp0.00%Mkt Cap: 6.34M $P/E: —1d ago
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifi…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap6.34M $
Enterprise Value5.22M $
Revenue (TTM)1.27M $
Gross Profit667.39K $
Net Income (TTM)-4.23M $
Revenue/Share0.0130 USD
Last Price5.650 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees9
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINCA68405H1001
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.64
EV/Revenue4.12
P/S4.87
P/B0.90
EPS (TTM)-0.04
EPS (Forward)—
52W Range
4.50013% of range13.50
52W High13.50 GBp
52W Low4.500 GBp
Profitability
Gross Margin52.66%
Oper. Margin-278.32%
EBITDA Margin-251.03%
Profit Margin-333.62%
ROE-61.92%
ROA-56.44%
Growth
Revenue Growth2.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.92M $
CapEx (TTM)—
FCF Margin-51.07%
FCF Yield-10.20%
Net Debt-1.13M $
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity—
Current Ratio4.27
Quick Ratio3.33
Book Value/Sh0.0610 GBp
Cash/Share0.0100 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:200
Split DateAug 5, 2014
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.103.30M
Float92.65M
Insiders11.38%
Institutions7.74%
Technical
SMA 506.006 (-5.9%)
SMA 2006.265 (-9.8%)
Beta1.82
S&P 52W Chg19.97%
Avg Vol (30d)147.16K
Avg Vol (10d)178.85K
Technical Indicators
RSI (14)41.3
MACD-0.0792
MACD Signal-0.0823
MACD Hist.+0.0031
BB Upper5.915 GBp
BB Middle5.715 GBp
BB Lower5.515 GBp
BB Width7.01%
ATR (14)0.3154 GBp
Vol Ratio (20d)2.43x